PTEN and malignant peripheral nerve sheath tumor: Similarly, although PTEN loss is not commonly observed as a primary genetic alteration in patients, PTEN downregulation has been proposed as a key contributor to disease progression, and Pten loss has therefore been incorporated into non-inducible murine MPNST models by others (Gregorian et al., 2009; Keng et al., 2012).